Protocol Development

The MEU’s experienced Clinical Pharmacologists approved to conduct FIH studies under the MHRA Phase 1 accredited scheme.

Based on a large teaching hospital site, we have access to specialist clinicians and ‘Key Opinion Leaders’ across the region to facilitate both recruitment and protocol development in terms of the appropriate patient population. The team has extensive experience in all aspects, covering clinical pharmacology, protocol design, safety, pharmacovigilance and patient recruitment strategies.